FAK is activated in late-stage cutaneous and uveal melanoma49, and inhibition of the FAT domain using Ad-FRNK50 or mutagenesis (Y925F)40 inhibits melanoma growth, invasion, and metastasis. This evidence concerns the gene PTK2 and melanoma.